| 產(chǎn)品名稱 |
#599 [S-599] |
| 商品貨號 |
B244871 |
| Designations |
#599 [S-599] |
| Species |
Homo sapiens, human |
| Depositors |
Otsuka Pharmaceuticals Co., Ltd., PM Arthur, Otsuka Pharmaceuticals Co., Ltd. |
| Applications |
contains sequence interleukin 1, beta produces protein interleukin 1, beta |
| Vector |
Construct size (kb): 4.578999996185303 |
| Insert |
DNA: cDNA Insert lengths(kb): 0.5860000252723694 Gene product: interleukin 1, beta [IL1beta] Target Gene: interleukin 1, beta |
| Insert Size (kb) |
0.586 |
| Media |
ATCC® Medium 1315: LB Medium (ATCC medium 1065) with 100 mg/L ampicillin
|
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| References |
Arthur PM, Duckworth BC. Gene regulation cassettes, expression vectors containing the same and microorganisms transformed with the same. US Patent 5,427,924 dated Jun 27 1995
|
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
